1. Home
  2. VALN vs CLW Comparison

VALN vs CLW Comparison

Compare VALN & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CLW
  • Stock Information
  • Founded
  • VALN 2012
  • CLW 2005
  • Country
  • VALN France
  • CLW United States
  • Employees
  • VALN N/A
  • CLW N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CLW Paper
  • Sector
  • VALN Health Care
  • CLW Basic Materials
  • Exchange
  • VALN Nasdaq
  • CLW Nasdaq
  • Market Cap
  • VALN 595.2M
  • CLW 481.8M
  • IPO Year
  • VALN 2021
  • CLW N/A
  • Fundamental
  • Price
  • VALN $7.44
  • CLW $27.30
  • Analyst Decision
  • VALN Strong Buy
  • CLW Buy
  • Analyst Count
  • VALN 2
  • CLW 1
  • Target Price
  • VALN $17.00
  • CLW $37.00
  • AVG Volume (30 Days)
  • VALN 81.7K
  • CLW 291.9K
  • Earning Date
  • VALN 03-20-2025
  • CLW 02-13-2025
  • Dividend Yield
  • VALN N/A
  • CLW N/A
  • EPS Growth
  • VALN N/A
  • CLW 85.68
  • EPS
  • VALN N/A
  • CLW 11.70
  • Revenue
  • VALN $176,817,979.00
  • CLW $1,383,600,000.00
  • Revenue This Year
  • VALN $22.73
  • CLW $14.27
  • Revenue Next Year
  • VALN $11.39
  • CLW N/A
  • P/E Ratio
  • VALN N/A
  • CLW $2.41
  • Revenue Growth
  • VALN N/A
  • CLW N/A
  • 52 Week Low
  • VALN $3.62
  • CLW $23.97
  • 52 Week High
  • VALN $9.50
  • CLW $57.13
  • Technical
  • Relative Strength Index (RSI)
  • VALN 60.56
  • CLW 39.33
  • Support Level
  • VALN $6.62
  • CLW $25.38
  • Resistance Level
  • VALN $8.42
  • CLW $32.55
  • Average True Range (ATR)
  • VALN 0.46
  • CLW 1.19
  • MACD
  • VALN 0.05
  • CLW -0.44
  • Stochastic Oscillator
  • VALN 69.85
  • CLW 26.78

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: